Search Results - "Stefano Fracchiolla, Nicola"
-
1
2,3,7,8-Tetrachlorodibenzo- p -dioxin (TCDD) role in hematopoiesis and in hematologic diseases: A critical review
Published in Toxicology (Amsterdam) (30-12-2016)“…Abstract Dioxin exposure and its effect on hematopoiesis and cancer have been largely investigated in both human and non-human settings. Here we systematically…”
Get full text
Journal Article -
2
The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects
Published in Frontiers in oncology (28-02-2020)“…T-cell acute lymphoblastic leukemia/lymphoma is an aggressive hematological neoplasm whose classification is still based on immunophenotypic findings…”
Get full text
Journal Article -
3
Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study
Published in PloS one (09-05-2019)“…Invasive fungal infections (IFIs) are a leading cause of morbidity and attributable mortality in oncohematologic patients. Timely diagnosis is essential but…”
Get full text
Journal Article -
4
-
5
Real-life monocentric experience of venetoclax-based regimens for acute myeloid leukemia
Published in Frontiers in oncology (27-03-2023)“…Combination of venetoclax and hypomethylating agents (HMAs) has become a standard of care in acute myeloid leukemia (AML) aged >75 years or who have…”
Get full text
Journal Article -
6
Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications
Published in Stem cells international (01-01-2017)“…The importance of the bone marrow microenvironment forming the so-called niche in physiologic hemopoiesis is largely known, and recent evidences support the…”
Get full text
Journal Article -
7
Acute myeloid leukemia and pregnancy: clinical experience from a single center and a review of the literature
Published in BMC cancer (23-06-2017)“…Acute myeloid leukemia (AML) accounts for more than two thirds of leukemia during pregnancy and has an incidence of 1 in 75,000 to 100,000. Its clinical…”
Get full text
Journal Article -
8
Secondary infections worsen the outcome of COVID‐19 in patients with hematological malignancies: A report from the ITA‐HEMA‐COV
Published in Hematological oncology (01-12-2022)“…The impact of secondary infections (SI) on COVID‐19 outcome in patients with hematological malignancies (HM) is scarcely documented. To evaluate incidence,…”
Get full text
Journal Article -
9
Real-world treatments and clinical outcomes in unfit AML patients receiving first-line treatment or best supportive care in Italy (CURRENT study)
Published in Leukemia research reports (2024)“…•The new aspect of the work. Provides real-life data on treatment patterns and clinical outcomes of patients with acute myeloid leukemia (AML) deemed unfit for…”
Get full text
Journal Article -
10
-
11
Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis
Published in Blood (15-02-2008)“…Various clinical prognostic scoring systems (PSSs) have been suggested as means of selecting high-risk chronic idiopathic myelofibrosis (CIMF) patients at…”
Get full text
Journal Article -
12
-
13
-
14
Prothrombotic Gene Mutations in Patients with Sudden Sensorineural Hearing Loss and Cardiovascular Thrombotic Disease
Published in Annals of otology, rhinology & laryngology (01-03-2009)“…Objectives: Impaired cochlear perfusion seems to be an important event in sudden sensorineural hearing loss. Prothrombotic gene mutations have been related to…”
Get full text
Journal Article -
15
Multiple adverse drug reactions during all-trans retinoic acid treatment for acute promyelocytic leukemia: differentiation syndrome, bradycardia, intestinal necrosis
Published in Exploration of targeted anti-tumor therapy (28-04-2020)“…All-trans retinoic acid (ATRA) induces complete remission in a high proportion of acute promyelocytic leukemia (APL). Nevertheless it is be associated with…”
Get full text
Journal Article -
16
P1686: LONG‐TERM COMORBIDITY AND HEALTH PROBLEMS IN ACUTE MYELOID LEUKEMIA (AML) SURVIVORS: AN INTERNATIONAL AML SURVIVORSHIP STUDY
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
17
High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study
Published in Journal of fungi (Basel) (29-05-2022)“…The potential drug-drug interactions of midostaurin may impact the choice of antifungal (AF) prophylaxis in FLT3-positive acute myeloid leukemia (AML)…”
Get full text
Journal Article -
18
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy
Published in Microbiology spectrum (31-10-2021)“…In one year of the coronavirus disease 2019 (COVID-19) pandemic, many studies have described the different metabolic changes occurring in COVID-19 patients,…”
Get full text
Journal Article -
19
An Unusual Coexistence of Primary Central Nervous System Non-Hodgkin’s Lymphoma and Acute Promyelocytic Leukemia
Published in Case reports in hematology (01-01-2018)“…Acute promyelocytic leukemia and primary central nervous system lymphoma are uncommon hematological malignancies. The co-occurrence of acute myeloid leukemia…”
Get full text
Journal Article -
20
An unusual type of myeloid sarcoma localization following myelofibrosis: A case report and literature review
Published in Leukemia research reports (2017)“…Myeloid Sarcoma (MS) is a rare malignancy that can present as an isolated disease or more frequently in association with or following acute myeloid leukemia or…”
Get full text
Journal Article